AJN’s October issue is now available on our Web site. Here’s a selection of what not to miss, including two continuing education (CE) articles, which you can access for free.
All women who inherit a BRCA1 or BRCA2 mutation have a significantly increased risk of developing breast or ovarian cancer or both. This month’s original research article, “Being Young, Female, and BRCA Positive,” explores the psychosocial consequences in young women who test positive for one of these mutations—especially where it concerns marriage and childbearing. This CE article is open access and can earn you 2.1 CE credits.
Diagnosis of celiac disease in adults is often missed or delayed because clinicians often consider it to be a childhood disease. “Celiac Disease: A Medical Puzzle,” provides an overview of this widely underrecognized disease, outlines the pathophysiology and the four types of celiac disease, addresses diagnosis and disease management, and offers illustrative stories in the interest of raising nurses’ awareness of the disease. This CE article is open access and can earn you 2.1 CE credits. For more information, listen to a podcast with the authors.
Being unaware of the realities of licensure can damage a nurse’s career, even permanently. “Common Misconceptions About Professional Licensure” is part one of a three-part series that will discuss nursing disciplinary actions and provides tips for maintaining one’s license in good standing. For more, listen to a podcast with the author, nurse and attorney Edie Brous.
The upcoming presidential election is pivotal for nurses and for the American people, particularly in terms of the candidates’ different approaches to the health care crisis. Do you know which platform you support? “The 2012 Republican and Democratic Health Care Platforms” gives you the information you need for the fall elections, plus opinions from key nursing leaders.
There is plenty more in this issue, so stop by and have a look. Feel free to tell us what you think on Facebook or our blog.
Comments are moderated before approval, but always welcome.